ICG-Guided Photodynamic Therapy for Treatment of Retinal Capillary Abnormalities: A Pilot Study

Status unconfirmed · Not applicable

Conditions studied: Retinal Vascular Disorders

In brief

The purpose of this research is to use an approved drug(Visudyne) for neovascular age-related macular degeneration, which is essentially choroidal neovascularization for permeability and vascular proliferation for the retinal circulation, to treat another permeable abnormality - retinal capillary abnormalities - located eccentric to the central portion of the macula or in the foveal region.

Key facts

Study ID

NCT01974622

Run by

Manhattan Eye, Ear & Throat Hospital

People needed

30

Starts

2013-04-01

Expected to finish

2015-06-01

Last updated by the study team

2013-11-01

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: accepted.

You may not qualify if…

• Patients whose diseases have approved methods of treatment.
• Pregnant women or women of normal child bearing age.

Where it is running

• Vitreous Retina Macula Consultants of New York — New York, New York, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.